Table 4.
Overall Survival | Disease-Specific Survival | |||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
(A) UNIVARIATE ANALYSES | ||||
Age at diagnosis | ||||
0–29 vs. 30–49 | 1.00 (0.50–1.99) | 0.999 | 1.08 (0.52–2.23) | 0.838 |
0–29 vs. 50–69 | 1.36 (0.70–2.67) | 0.365 | 1.20 (0.58–2.45) | 0.625 |
0–29 vs. ≥ 70 | 2.12 (1.09–4.13) | 0.026 | 1.84 (0.91–3.75) | 0.090 |
Sex | ||||
Female vs. Male | 0.93 (0.77–1.12) | 0.433 | 0.93 (0.75–1.14) | 0.468 |
Race | ||||
Black vs. White | 1.25 (0.83–1.89) | 0.292 | 1.08 (0.69–1.71) | 0.726 |
Black vs. Othersa | 0.86 (0.65–1.14) | 0.283 | 0.76 (0.56–1.03) | 0.072 |
Marital status | ||||
Married vs. Unmarried | 1.26 (1.05–1.51) | 0.0134 | 1.43 (1.17–1.76) | <0.001 |
Surgery | ||||
No/unknown vs. Performed | 0.57 (0.33–0.99) | 0.0474 | 0.57 (0.30–1.06) | 0.075 |
Radiation | ||||
No/unknown vs. Performed | 0.99 (0.67–1.46) | 0.969 | 0.91 (0.58–1.42) | 0.665 |
Chemotherapy | ||||
No/unknown vs. Performed | 0.34 (0.28–0.41) | <0.001 | 0.34 (0.27–0.42) | <0.001 |
(B) MULTIVARIATE ANALYSES | ||||
Age at diagnosis | / | |||
0–29 vs. 30–49 | 1.21 (0.61–2.41) | 0.586 | / | / |
0–29 vs. 50–69 | 1.83 (0.93–3.62) | 0.080 | / | / |
0–29 vs. ≥ 70 | 2.53 (1.29–4.96) | 0.006 | / | / |
Marital status | ||||
Married vs. Unmarried | 1.34 (1.11–1.62) | 0.002 | 1.33 (1.09–1.64) | 0.005 |
Surgery | / | |||
No/unknown vs. Performed | 0.63(0.36–1.09) | 0.100 | / | / |
Chemotherapy | ||||
No/unknown vs. Performed | 0.36 (0.30–0.44) | <0.001 | 0.35 (0.28–0.43) | <0.001 |
American Indian/Alaskan Native or Asian/Pacific Islander.